Endometrial Carcinosarcoma
📧 Sign up to get email alerts when something new happens for Endometrial Carcinosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma [Phase 2]
Phase 2 study updating pembrolizumab with olaparib in endometrial carcinosarcoma has completed.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma [Phase 3]
A Phase 3 clinical trial is evaluating the addition of Herceptin Hylecta or Phesgo to standard chemotherapy for HER2-positive endometrial se…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma [Phase 2]
Phase 2 study evaluating pembrolizumab plus olaparib for endometrial cancer and endometrial carcinosarcoma is currently active but not recru…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the Wee1 inhibitor adavosertib (AZD1775) in women with recurrent or persiste…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib [Phase 2, Phase 3]
A phase 2/3 trial evaluating Niraparib in combination with anti-PD-1 therapy for recurrent ovarian carcinosarcoma and endometrial carcinosar…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment [Phase 2]
A Phase 2 clinical trial evaluating the combination of BMS-986205 and nivolumab in patients with endometrial adenocarcinoma or endometrial c…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer [Phase 2]
Phase 2 study evaluating durvalumab with or without tremelimumab in endometrial cancer and carcinosarcoma has completed with results posted.